MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up.
Maat Pharma has raised €25M across 2 funding rounds from 1 investor, most recently a Series B round in Dec 2020. Based in Lyon, France; founded 2014; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2020-12-02 | Series B | €7.3M | PSIM Fund | View deal → |
| 2020-05-02 | Series B | €18M | — | View deal → |
